This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Amylin Pharmaceuticals, Inc., Astrazeneca Pharmaceuticals LP. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 164 
1 out of 40 
Years Active: 2013
Title: David G Maggs: Innovator in Metabolic Disease Treatment
Introduction
David G Maggs is a notable inventor based in San Diego, CA. He has made significant contributions to the field of metabolic disease treatment, particularly through his innovative patent related to incretin compounds.
Latest Patents
David G Maggs holds a patent for the use of Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease. The present invention relates generally to the novel use of incretin compounds and amylinomimetic compounds to treat, prevent, or ameliorate a variety of metabolic conditions or diseases. This patent highlights his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, David has worked with prominent companies in the pharmaceutical industry, including AstraZeneca Pharmaceuticals LP and Amylin Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of treatments for metabolic diseases.
Collaborations
David G Maggs has collaborated with notable professionals in his field, including Dennis Kim and Matthew Wintle. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
David G Maggs is a distinguished inventor whose work in the treatment of metabolic diseases has made a significant impact. His innovative patent and collaborations with leading professionals underscore his dedication to improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile